The prevalence of all stype of diabetes and pre‑diabetes in the Eastern Mediterranean countries: a meta‑analysis study
- PMID: 40596951
- PMCID: PMC12211881
- DOI: 10.1186/s12902-025-01959-4
The prevalence of all stype of diabetes and pre‑diabetes in the Eastern Mediterranean countries: a meta‑analysis study
Abstract
Background and aim: Given the high prevalence, incidence, and impact on Disability-Adjusted Life Years (DALYs) associated with diabetes, coupled with the limited availability of meta-analysis studies examining its prevalence in the Eastern Mediterranean Regional Office (EMRO) countries, the main objective of this study was to investigate the combined prevalence of type 1 (T1DM) and type 2 diabetes (T2DM), gestational diabetes, and pre-diabetes within the Eastern Mediterranean region.
Methods: To implement a comprehensive search strategy aligned with the objectives of this meta-analysis, searches were conducted across international databases, including PubMed (Medline), Scopus, Embase, Web of Science, and the Cumulative Index to Nursing and Allied Health Literature (CINHAL) from January 1967 to December 2022. The quality of the selected studies was assessed using the JBI critical appraisal checklist for analytical cross-sectional studies. Subgroup analyses were conducted based on factors such as gender, country, geographic area, criteria for diagnosis, and Gross Domestic Product (GDP) level.
Results: Out of 5,238 primary studies initially screened, 186 articles were included in the meta-analysis. The pooled prevalence of diabetes was found to be 15% (95% CI: 13 - 16%), of which 6% (95% CI: 4 - 7%) represented undiagnosed cases, while 8% (95% CI: 7 - 10%) were known cases. The prevalence of T2DM was 13% (95% CI: 11 - 16%), while T1DM was found to have a prevalence of 1% (95% CI: 1 - 2%). Pre-diabetes had a pooled prevalence of 15% (95% CI: 13 - 18%), with impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) representing 9% (95% CI: 7 - 11%) and 8% (95% CI: 6 - 11%) of cases, respectively. The prevalence of gestational diabetes mellitus (GDM) was found to be 11% (95% CI: 9 - 14%) in the EMRO.
Conclusion: The findings emphasize the need for enhanced healthcare programs, including early screening, effective management, and lifestyle interventions such as healthy eating and physical activity. The analysis also highlights the importance of considering socioeconomic factors like urbanization, diet changes, and healthcare access when developing diabetes prevention and management strategies. The results call for policymakers and healthcare providers to collaborate in addressing the growing public health burden of diabetes in the region.
Keywords: Diabetes Mellitus; EMRO; Gestational Diabetes Mellitus; Meta-analysis; Pre-Diabetes; Prevalence.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was reviewed and approved by the Research Ethics Committees of Kurdistan University of Medical Sciences Medicine. The project was found to be by the ethical principles and the national norms and standards for conducting Medical Research in Iran. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843. JBI Database System Rev Implement Rep. 2016. PMID: 27532314
-
Lifestyle interventions for the treatment of women with gestational diabetes.Cochrane Database Syst Rev. 2017 May 4;5(5):CD011970. doi: 10.1002/14651858.CD011970.pub2. Cochrane Database Syst Rev. 2017. PMID: 28472859 Free PMC article.
-
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116. Eur J Endocrinol. 2025. PMID: 40652450
-
Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.Cochrane Database Syst Rev. 2017 Dec 4;12(12):CD003054. doi: 10.1002/14651858.CD003054.pub4. Cochrane Database Syst Rev. 2017. PMID: 29205264 Free PMC article.
-
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.Cochrane Database Syst Rev. 2015 Dec 17;2015(12):CD011507. doi: 10.1002/14651858.CD011507.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2023 Feb 15;2:CD011507. doi: 10.1002/14651858.CD011507.pub3. PMID: 26678256 Free PMC article. Updated.
References
-
- Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Handb Clin Neurol. 2014;126:211–22. - PubMed
-
- Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. Adv Exp Med Biol. 2012;771:1–11. - PubMed
-
- Unwin N, Alberti K. Chronic non-communicable diseases. Ann Trop Med Parasitol. 2006;100(5–6):455–64. - PubMed
-
- Federation ID. International Diabetes Federation.IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. 2021 [Available from: https://www.diabetesatlas.org.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous